Ceftriaxone powder for solution for and injection/ infusion

Country: আর্মেনিয়া

ভাষা: ইংরেজি

সূত্র: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

সক্রিয় উপাদান:

ceftriaxone (ceftriaxone sodium)

থেকে পাওয়া:

PharmaTech CJSC

এটিসি কোড:

J01DD04

INN (International Name):

ceftriaxone (ceftriaxone sodium)

ডোজ:

1000mg

ফার্মাসিউটিকাল ফর্ম:

powder for solution for and injection/ infusion

প্যাকেজ ইউনিট:

(50) vial 10ml

প্রেসক্রিপশন টাইপ:

Prescription

অনুমোদন অবস্থা:

Registered

অনুমোদন তারিখ:

2022-05-30

তথ্য লিফলেট

                                PharmaTech CJSC 111 Raffi st. Yerevan, 0064 Republic of Armenia Tel:
+3741 74 14 10 Fax: +3741 73 46 43
1
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
CEFTRIAXONE
1G
POWDER FOR SOLUTION FOR INJECTION OR INFUSION
Ceftriaxone (as Ceftriaxone Sodium)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE
BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor, pharmacist or
nurse.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Ceftriaxone is and what it is used for
2.
What you need to know before you are given Ceftriaxone
3.
How Ceftriaxone is given
4.
Possible side effects
5.
How to store Ceftriaxone
6.
Contents of the pack and other information
1.
WHAT CEFTRIAXONE IS AND WHAT IT IS USED FOR
Ceftriaxone is an antibiotic given to adults and children (including
newborn babies). It works by
killing bacteria that cause infections. It belongs to a group of
medicines called cephalosporins_. _
Ceftriaxone is used to treat in fections of:
•
the brain (meningitis).
•
the lungs.
•
the middle ear.
•
the abdomen and abdominal wall (peritonitis).
•
the urinary tract and kidneys.
•
bones and joints.
•
the skin or soft tissues.
•
the blood.
•
the heart.
PharmaTech CJSC 111 Raffi st. Yerevan, 0064 Republic of Armenia Tel:
+3741 74 14 10 Fax: +3741 73 46 43
2
It can be given:
•
to treat specific sexually transmitted infections (gonorrhoea and
syphilis).
•
to treat patients with low white blood cell counts (neutropenia) who
have fever due to bacterial
infection.
•
to treat infections of the chest in adults with chronic bronchitis.
•
to treat Lyme disease (caused by tick bites) in adults and children

                                
                                সম্পূর্ণ নথি পড়ুন
                                
                            

পণ্য বৈশিষ্ট্য

                                SUMMARY O
F
PRODUCT CHARACTERISTICS
1
NAME O
F
THE MEDICINAL PRODUCT
Ceftriaxone
1
g Powder for solution for injection or infusion.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Ceftriaxone
1
g powder for solution for injection or infusion
Each vial contains
1
g ceftriaxone as ceftriaxone sodium.
3
PHARMACEUTICAL
F
ORM
1 g powder for solution for injection or infusion
Powder for solution for injection or infusion.
White to yellowish-orange crystalline powder.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Ceftriaxone is indicated for the treatment of
the following infections in adults and
children including term neonates (from birth):
Bacterial Meningitis
Community acquired pneumonia
Hospital acquired pneumonia
Acute otitis media
Intra-abdominal infections
Complicated urinary tract infections (including pyelonephritis)
Infections of bones and joints
Complicated skin and soft tissue infections
Gonorrhoea
Syphilis
Bacterial endocarditis
Ceftriaxone may be used:
For treatment of acute exacerbations of chronic obstructive pulmonary
disease
in adults
For treatment of disseminated Lyme borreliosis (early (stage II) and
late (stage
III)) in adults and children including neonates from 15 days of age.
For pre-operative prophylaxis of surgical site infections
In the management of neutropenic patients
with fever that is suspected to be due
to a bacterial infection
In the treatment of patients with bacteraemia that occurs in
association with, or
is suspected to be associated with, any of the infections listed above
Ceftriaxone should be co-administered with
other antibacterial agents whenever the
possible range of causative bacteria would
not fall within its spectrum (see section
4.4).
Consideration should be given to official
guidelines on the appropriate use of
antibacterial agents.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The dose depends on the severity, susceptibility, site and type of
infection and on the
age and hepato-renal function of the patient.
The doses recommended in the tables below are the generall
                                
                                সম্পূর্ণ নথি পড়ুন
                                
                            

এই পণ্য সম্পর্কিত সতর্কতা অনুসন্ধান করুন